Copyright
©The Author(s) 2023.
World J Gastroenterol. Aug 21, 2023; 29(31): 4744-4762
Published online Aug 21, 2023. doi: 10.3748/wjg.v29.i31.4744
Published online Aug 21, 2023. doi: 10.3748/wjg.v29.i31.4744
Figure 9 Schematic diagram illustrating the effects of Huangqin decoction on Sirt1/NF-κB pathway-modulated hepatic steatosis and insulin resistance.
CD36: Cluster of differentiation 36; FAS: Fatty acid synthase; HFD: High-fat diet; HQD: Huangqin decoction; IL: Interleukin; SREBP: Sterol regulatory element-binding protein; TNF: Tumor necrosis factor.
- Citation: Yan BF, Pan LF, Quan YF, Sha Q, Zhang JZ, Zhang YF, Zhou LB, Qian XL, Gu XM, Li FT, Wang T, Liu J, Zheng X. Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway. World J Gastroenterol 2023; 29(31): 4744-4762
- URL: https://www.wjgnet.com/1007-9327/full/v29/i31/4744.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i31.4744